Aspirin Benefit for Primary Prevention in High-Risk T2D - Observational Analysis: AHA 2025 Abstract Dr. Nitin Gudage17 Feb 2026 12:00 PM ISTFor years, the medical community has sought the ideal balance for aspirin in primary prevention. New evidence from the American Heart Association...
USV Acquires 79% Stake in Wellbeing Nutrition, Values D2C Startup at Rs 1,583 Cr Susmita Roy13 Feb 2026 1:44 PM ISTNew Delhi: USV Pvt Ltd, widely recognised for its leading brands in diabetes and cardiovascular therapy, has acquired a 79 percent stake in...
Lifestyle-Linked CV Risk: Where Does Aspirin Fit? Dr. Nishant Tripathy13 Feb 2026 12:45 PM ISTIndia faces a rapidly evolving cardiometabolic risk landscape, with overweight and obesity affecting 23.5% and 6.7% of adults, alongside escalating...
Early-Onset Hypertension and Elevated ASCVD Risk: When Does Aspirin Fit? Dr. Laxman Gaikwad1 Jan 2026 11:30 AM ISTThe epidemiology of hypertension in India has undergone a malignant shift, moving from a disease of the elderly to a pervasive condition in the...
Cardio-Metabolic Risk and Aspirin: What Does the Evidence Say for Indian Patients? Dr. Deepak Gupta19 Dec 2025 11:30 AM ISTIndia carries a heavy cardiometabolic burden of nearly 30%, intensified by early-onset diabetes, hypertension, dyslipidaemia, and obesity patterns...
Aspirin in Obese T2D with Atherogenic Dyslipidemia: Identifying the Ideal Candidates Dr. Srinivas Kudva12 Nov 2025 12:00 PM ISTIndia faces a rapidly escalating triple syndemic of obesity, type 2 diabetes (T2D), and atherogenic dyslipidemia, conditions that frequently overlap...
Risk Beyond Control: Inherited and Causal CV Risk Factors and the Role of Aspirin Dr. Prakash Kumar11 Nov 2025 11:30 AM ISTCardiovascular diseases (CVDs) are the leading cause of non-communicable disease (NCD) deaths in India, accounting for nearly 48% of all NCD...
Identifying Aspirin Candidates for Primary Prevention: Focus on Men Aged 40- 50 with Metabolic Syndrome and Cardiometabolic Risk Lalhmangaihkimi29 Sept 2025 12:15 PM ISTUnique CV Risk in India- Epidemiological BackdropCardiovascular diseases (CVDs) remain the leading cause of death in India, with a WHO-reported...
Young, Diabetic, and at High CV Risk: Is It Time for Early Aspirin? Dr. Amit V. Joshi18 Aug 2025 11:47 AM ISTYoung, Diabetic, and at High CV Risk: A Case for Early CV Prevention with Aspirin in the High-Risk Young
Aspirin in Primary Prevention of Stroke-Review of Evidence Through the Needs of Indian Clinical Settings Dr. Rahul R. Patil7 July 2025 11:42 AM ISTIntroduction: Stroke Burden and Aspirin's RoleThe stroke burden in India is substantial and growing, with an incidence of 119-145 per 100,000 annually...
Identifying Candidates for Aspirin in Primary Prevention: Men Aged 40-50 with Hypertension, Dyslipidemia, and Familial ASCVD Risk Pradeep Eswarappa Haranahalli1 July 2025 11:03 AM ISTPremature ASCVD: Why Age 40-50 Males Need Closer Attention? Premature ASCVD is rising sharply in Indian men aged 40-50, demanding earlier...
Aspirin in Primary Prevention: Prudent Guideline-Based Approach Prof. (Dr.) J.P.S. Sawhney13 Jun 2025 11:44 AM ISTAspirin in Primary Prevention: Need for Delineating High CV-Risk, Low-Bleeding-Risk Profiles: Aspirin in primary prevention requires a nuanced,...
